John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 4,986 shares at $112.26 ($560K) on 2022-01-01, disclosed to the SEC on 2022-03-04.
Open-market sale of $560k NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.26 | 2,493 | $280K | 50.0% |
| 2 | $112.26 | 2,493 | $280K | 50.0% |
| Total | $112.26 avg | 4,986 | $560K | 100% |
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |